Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Real Life Experience Survey of Dupilumab in the Netherlands
- Status
- COMPLETED
- Phase
- N/A
Ethnic Differences in Mechanisms of Action of Dupilumab
- Status
- RECRUITING
- Phase
- PHASE4
Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.
- Status
- UNKNOWN
- Phase
- PHASE4
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis
- Status
- COMPLETED
- Phase
- PHASE4
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
- Status
- RECRUITING
- Phase
- N/A
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids
- Status
- COMPLETED
- Phase
- PHASE2
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE4
Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE4
Dupilumab_Metastatic NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
- Status
- COMPLETED
- Phase
- PHASE4
Dupilumab in the Treatment of Keloids
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Compassionate Use of Dupilumab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- Status
- RECRUITING
- Phase
- PHASE4
Similarities and Differences of Biological Therapies for Severe Asthma.
- Status
- UNKNOWN
- Phase
- N/A